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cellular TASK proteins suppress transcription of
unintegrated HIV-1 DNA
Nkiruka Emeagwali1 and James EK Hildreth2*Abstract
Background: Unintegrated HIV-1 DNA serves as transcriptionally active templates in HIV-infected cells. Several host
factors including NF-κβ enhance HIV-1 transcription. HIV-1 induced NF-κβ activation can be suppressed by viral
protein U (Vpu). Interestingly HIV-1 Vpu shares amino acid homology with cellular Twik-related Acid Sensitive
K+ (TASK) channel 1 and the proteins physically interact in cultured cells and AIDS lymphoid tissue.
Furthermore, the first transmembrane domain of TASK-1 is functionally interchangeable with Vpu and like Vpu
enhances HIV-1 release.
Results: Here we further characterize the role of TASK channels and Vpu in HIV-1 replication. We demonstrate
that both TASK channels and Vpu can preferentially inhibit transcription of unintegrated HIV-1 DNA.
Interestingly, TASK-1 ion channel function is not required and suppression of HIV-1 transcription by TASK-1
and Vpu was reversed by overexpression of RelA (NF-κβ p65).
Conclusion: TASK proteins and Vpu suppress transcription of unintegrated HIV-1 DNA through an
NF-κβ-dependent mechanism. Taken together these findings support a possible physiological role for HIV-1
Vpu and TASK proteins as modulators of transcription of unintegrated HIV-1 DNA genomes.
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Human immunodeficiency virus type 1 (HIV-1) replica-
tion involves a series of highly orchestrated steps that
are regulated by both viral and cellular factors. Like
other retroviruses, HIV-1’s genome is reverse transcribed
before the proviral DNA integrates into host cell chro-
matin. HIV-1 proviral DNA preferentially integrates into
open transcriptionally active sites in the host cell chro-
matin where robust viral gene transcription can occur.
Integration of HIV-1 DNA, mediated by viral integrase,
allows the viral genome to persist throughout the life-
span of the cell. However, despite the critical role of in-
tegration in the lifecycle of all retroviruses, during the
course of HIV-1 infection the majority of viral DNA
remains unintegrated [1].* Correspondence: jekhildreth@ucdavis.edu
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distribution, and reproduction in any mediumUnintegrated HIV-1 DNA (uDNA) is generated during
virus replication and serves as DNA templates for tran-
scription. The majority of viral uDNA genomes remain
linear. Linear HIV-1 DNA, the substrate for integration,
is found in both the cytoplasm and nucleus and can be
degraded or modified by host factors [1-3]. uDNA can
circularize by homologous recombination [4] or ligation
of interrupted reverse transcription intermediates [5]
to form 1-LTR circles. uDNA can also circularize by
non-homologous end joining DNA repair events to
form 2-LTR circles [6,7]. In addition, formation of 1-LTR
and 2-LTR circles can result from activity of host factors
involved in DNA repair. Circular forms of the viral gen-
ome are found exclusively in the nucleus. Interestingly,
the host restriction factor APOBEC3G has been shown to
cause a 2-fold decrease in 2-LTR circle formation in cells
infected with Δvif HIV-1 [8].
In HIV-1-infected patients, high levels of uDNA can
be found in the blood, lymphoid tissues, and brain
[1,6,9-12]. uDNA also accumulates in non-dividing cellsed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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iding cells through dilution during cell division [13-15].
Clinically, detection of high levels of uDNA in the brain is
associated with development of AIDS dementia and
correlates with a decline in CD4+ T cells. In addition,
uDNA templates are increased in HIV-infected cells of
patients given ART regimens with the integrase inhibi-
tor, Raltegravir. The accumulation of uDNA in patients
appears to be independent of viral load [16,17].
Several studies have characterized important roles for
uDNA with respect to HIV-1 infection [18-24]. Linear
uDNA is the form used by HIV-1 integrase to incorpor-
ate the viral genome into host cell chromatin. uDNA
can contribute to virus genetic diversity by providing
templates for viral genome complementation of the inte-
grated HIV-1 genome during virus assembly and pro-
duction [25,26]. Transcriptional activity in uDNA is
lower than that of integrated genomes. However, early
gene products of HIV-1 infection, Tat and Nef, are tran-
scribed and translated in cells containing only uDNA
[20,24,27,28]. Nef protein production from uDNA is suf-
ficient to promote T cell activation, down regulate CD4
and enhance HIV-1 infection [24]. Tat, an important
viral protein in HIV replication, is initially produced
from uDNA. Tat production from uDNA transactivates the
HIV-1 LTR of both uDNA and integrated HIV-1 DNA [29].
Transcription of uDNA is enhanced by viral protein R
(Vpr) a late gene product of HIV-1 infection. Interestingly
both virion-associated Vpr and newly synthesized Vpr pre-
ferentially increase transcription of nef from uDNA tem-
plates [30]. Another late gene product of HIV-1 infection
is viral protein U (Vpu). Vpu promotes the efficient release
of virus particles from the cell surface, induces the degrad-
ation of CD4 in the ER and suppresses the activation of
NF-κβ [31-33]. Vpu also restricts the function of several
host proteins including tetherin and Twik-related Acid
Sensitive K+ channel-1 (TASK-1) [34,35]. TASK proteins
are a part of the family of two-pore domain background
potassium (K(2P)) channels.
TASK channels are widely expressed by many cell
types and establish resting membrane potential and cell
excitability. They are functional as dimers and have been
shown to form homo- and heterodimers in vivo [36].
Hsu et al. demonstrated that HIV-1 Vpu shows a high
degree of sequence similarity to the first transmembrane
domain of TASK-1 (Ttm1) [34]. In addition, Vpu can
self-assemble into homo-oligomeric complexes and form
ion channels in lipid bilayers. Interestingly Vpu’s ion
channel function is not required to antagonize CD317-
mediated restriction of HIV release [37,38]. In their
study characterizing the homology between Vpu and the
first transmembrane domain of TASK-1, Hsu et al.
demonstrated that Vpu and Ttm1 were each capable of
functional inhibition of the other. Furthermore it wasfound that cells infected with Vpu-deleted HIV-1, NL4-3
Udel, produced low levels of virus and this was reversed
when Ttm1 was expressed in trans [34].
These observations suggest that some form of molecu-
lar piracy may have occurred during the evolution of
HIV-1 infection. Here we demonstrate for the first time
that TASK proteins and Vpu preferentially suppress
transcription of uDNA. Our results have important
implications for further understanding host-pathogen
interactions that regulate HIV-1 replication and
pathogenesis.
Results
Overexpression of TASK-1 suppresses HIV-1 replication
We sought to extend this finding from a previous study
that demonstrated that TASK-1 suppressed HIV replica-
tion [34]. 293T cells were cotransfected with HIV-1
pNL4-3 and TASK-1. After 48 hours, supernatants were
collected and HIV-1 was quantified with a capture p24
antigen ELISA. Our results show that virus release was
reduced by 82.5% in HIV-1-infected cells overexpressing
TASK-1 protein compared to cells transfected with the
empty vector control (Figure 1a, 1b). This result confirms
the findings of Hsu and co-workers who demonstrated a
decrease in HIV-1 release from HeLa cells co-
transfected with pNL4-3 and TASK-1. We obtained
similar data when 293T cells were co-transfected with
pNL4-3 along with human TASK-3, murine TASK-1 or
murine TASK-3. In addition, we also accessed the ef-
fect of TASK overexpression on cell viability and
observed no decrease in viability resulting from TASK
overexpression (data not shown). These results indicate
that the effect of TASK-1 on HIV-1 release does not result
from cellular toxicity and is shared with other TASK pro-
teins, independent of species.
Assembly and budding of progeny virions from infected
cells comprise the late stages of HIV-1 biogenesis and are
multi-step events driven by the viral protein Gag. Indeed,
transient expression of Gag alone is sufficient for the for-
mation of virus-like particles (VLPs) consistent with the
central role of Gag in particle assembly and release. To
evaluate the effect of TASK proteins on the late stages of
the HIV-1 life cycle, particle release from 293T cells
co-expressing Gag driven by a CMV promoter and
TASK-1 was evaluated. We observed no difference in
Gag-mediated VLP release from cells in the presence or
absence of TASK-1 protein (Figure 1c, 1d). Similarly using
provirus HIV-1 SG3 containing a neomycin phospho-
transferase (NPT) gene under the transcriptional regula-
tion of SV40 we observed no change in NPT protein
levels with TASK protein expression while HIV-1 Gag
protein under the control of the LTR promoter was sig-
nificantly decreased (data not shown). These findings indi-
cate that the effect of TASK proteins on HIV-1 replication
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Figure 1 TASK-1 suppresses HIV-1 replication. A. 293T cells were co-transfected with pNL4-3 and TASK-1 expression vector or empty vector.
After 48 hours supernatants were collected and a p24 ELISA was performed. Data are normalized to the empty vector control (EV). B. TASK-1
expression in transfected cells. 293T cells were harvested and lysed with buffer containing protease inhibitors. Equal amounts of protein from cell
lysates were separated by 4-12% SDS-PAGE and transferred onto nitrocellulose membranes. TASK and β-tubulin proteins were detected by
immunoblotting using polyclonal antibodies and visualization by chemilumenescence. C. TASK-1 does not decrease HIV-1 Gag virus-like particle
release. 293T cells were co-transfected with plasmid encoding Gag driven by CMV promoter and TASK-1 or empty vector. After 48 hours
supernatants were collected, and a p24 ELISA was performed. Data are normalized to the empty vector control (EV). D. TASK-1 expression in
transfected cells from (C). 293T cells from (C.) were harvested and lysed with a detergent buffer containing protease inhibitors. Equal protein
amounts of cell lysate were separated by 4-12% SDS-PAGE and transferred to nitrocellulose membranes. TASK and β-tubulin proteins were
revealed by immunoblotting using polyclonal antibodies followed by chemilumenescence detection. (* P < .0001; Student T test was used to
determine statistical significance).
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thermore TASK protein expression preferientally sup-
presses gene transcription driven by the HIV-LTR but not
transcription from CMV or SV40 promoters.
Since the late stages of virus replication were not affected
by TASK protein overexpression we examined the effect of
TASK protein expression on the earlier stages of HIV-1
replication. 293T cells were cotransfected with pNL4-3 and
TASK-3 or empty vector. After 48 hours intracellular Gag
from cell lysates was quantified with a capture p24 antigen
ELISA. We found that overexpression of TASK proteins
decreased intracellular Gag by over 83% (data not shown).
TASK-1 protein suppresses HIV-1 transcription
One possible explanation for the decrease in both extracel-
lular and intracellular Gag expression in cells overexpressing
TASK proteins is suppression of HIV-1 gene transcription.To test this possibility, a reporter virus construct derived
from pNL4-3 in which the luciferase gene is substituted for
nef (pNL4-3Luc), was cotransfected into 293T cells along
withTASK-1. After 48 hours, the transfected cells were lysed
and a luciferase assay was performed to measure HIV-1
LTR-dependent transcription. Overexpression of TASK-1
significantly inhibited HIV-1 transcription, and this inhib-
ition was dose-dependent (Figure 2a, 2c). Similar results
were obtained when cells were co-transfected with TASK-3
and the reporter virus construct (data not shown). Taken to-
gether, these results indicate that TASK protein suppresses
HIV-1 replication by inhibition of viral transcription.
TASK channel function is not required for suppression of
HIV-1 transcription
TASK proteins are potassium channels whose ion chan-
nel function contributes significantly to maintaining the
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Figure 2 TASK proteins suppress HIV-1 transcription. A. 293T cells were transfected with pNL4-3Luc and TASK-1 expression vector or empty
vector (EV). After 48 hours cells were lysed and a luciferase assay was performed to determine the effect of TASK-1 on HIV-1 transcription. Data
are normalized to the empty vector control (EV). B. Transfected 293T cells were harvested and lysed with a detergent buffer containing protease
inhibitors. Equal protein amounts of cell lysate were separated by 4-12% SDS PAGE and transferred to nitrocellulose membranes. TASK and β-
tubulin proteins were revealed by immunoblotting with polyclonal antibodies followed by chemilumenescence detection. C. 293T cells were
transfected with pNL4-3Luc and 0.5ug, 1ug, or 2ug TASK-1 or empty vector. After 48 hours cells were lysed and a luciferase assay was performed.
Data are normalized to the empty vector control (EV). D. Transfected 293T cells from (C.) were harvested, lysed and equal amounts of protein
from cell lysates were subjected to 4-12% SDS PAGE. After transfer to nitrocellulose membranes, TASK and β-tubulin proteins were revealed by
immunoblotting with polyclonal antibodies followed by chemilumenescence detection. (* P < .0001; Student T test was used to determine
statistical significance).
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ion channels have phenotypes independent of their ion
channel activity. One example, the Ether-à-go-go (EAG)
K+ channels regulates intracellular signaling pathways
by a mechanism that depends on the position of its volt-
age sensor [39]. Therefore to examine whether TASK
ion channel function was required for suppression of
HIV-1 transcription we co-transfected 293T cells with
pNL4-3Luc and either a dominant negative TASK-1
(Y191F) or TASK-5. TASK-5 is a naturally occurring
non-functional TASK protein that is homologous to
TASK-1 and TASK-3 [40]. In addition, we added 5mM
BaCl2 to pharmacologically block TASK function in cells
transfected with wild type TASK-1 and a luciferase assay
was performed after 48 hours. Our results show that the
dominant negative TASK-1 mutant TY191F and the nat-
urally non-functional channel TASK-5 were both able to
suppress HIV-1 transcription similar to wildtype TASKproteins (Figure 3a). Furthermore, wild type TASK chan-
nels in the presence of 5mM BaCl2 were also able to
suppress HIV-1 transcription (Figure 3b, 3c). Therefore,
TASK ion channel function is not required to suppress
HIV-1 transcription. In addition, suppression of HIV-1
transcription appears to be specific to TASK protein
family members because an inwardly-rectifying K chan-
nel (IRK1), from a different K+ channel family, enhanced
rather than suppressed HIV-1 transcription (data not
shown).
Both HIV-1 Vpu and TASK protein decrease HIV-1
transcription
As noted above, the first transmembrane domain of
TASK-1 (Ttm1) shares amino acid identity with HIV-1
Vpu and can reverse defects in HIV-1 release when
added in trans to cells transfected with the Δvpu HIV-1
provirus pNL4-3-Udel [34]. In addition, Vpu has been
AB
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Figure 3 TASK channel function is not required for suppression of HIV-1 transcription. A. 293T cells were transfected with pNL4-3Luc and
either wild type TASK-1 or non-functional TASK protein expression vectors as described in the text. After 48 hours a luciferase assay was
performed to determine the effect of ion channel function on TASK-1’s ability to suppress HIV-1 transcription. Data shown are normalized to
empty vector control (EV). B. 293T cells were transfected with pNL4-3Luc and wild type TASK-1 in the presence of the ion channel inhibitor
5mM BaCl2. After 48 hours a luciferase assay was performed to measure HIV-1 transcription. Data are normalized to the empty vector
control (EV). C. Transfected 293T cells were harvested, lysed and equal amounts of cell lysate protein were subjected to 4-12% SDS-PAGE.
After transfer to nitrocellulose membranes, TASK and β-tubulin proteins were revealed by immunoblotting with polyclonal antibodies
followed by chemilumenescence detection. (* P < .001; Statistical analysis was performed on the samples using a student T test).
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To determine if, like TASK proteins, Vpu could also sup-
press HIV-1 transcription, 293T cells were cotransfected
with pNL4-3Luc and a Vpu expression construct in in-
creasing concentrations. After 48 hours, a luciferase
assay was performed to measure viral transcription. Like
TASK-1, Vpu significantly suppressed HIV-1 transcrip-
tion in a dose-dependent manner (Figure 4a, 4b). We
also performed a cell viability assay and found no change
in cell viability with expression of Vpu (data not shown).
Interestingly Vpu suppressed HIV-1 transcription by
90%, a level of suppression even greater than that
mediated by TASK-1.
To determine if the HIV-1 Tat protein was involved in
suppression of HIV-1 transcription by TASK and Vpu,
we co-transfected 293T cells with an HIV-1-LTR-GFP
plasmid along with empty vector, TASK-1 or Vpu cDNA
in trans and measured expression of HIV-1-LTR-
dependent GFP by flow cytometry after 48 hours. The
HIV-1-LTR-GFP plasmid does not include the tat gene
and in the absence of Tat there was a low level of en-
dogenous HIV LTR promoter activity. However as previ-
ously seen in Figures 2 and 4a both Vpu and TASKsignificantly suppressed HIV-1 transcription in the ab-
sence of Tat (Figure 4c). These results showed that Vpu
and TASK-1 suppress HIV-1 transcription in a Tat-
independent manner.
TASK and Vpu proteins preferentially suppress
unintegrated HIV-1 DNA
We have shown that TASK proteins and Vpu suppress
viral transcription in cells transfected with HIV-1 pro-
viral DNA. During these transient transfection assays,
the HIV-1 provirus remains unintegrated. Therefore we
sought to examine the effect of TASK and Vpu proteins
on HIV-1 transcription from integrated and unintegrated
viral genomes. For this purpose we determined the effect
of TASK and Vpu expression on HIV-1 transcription in
cells that had contained an integrated and an uninte-
grated viral genome. We used the JLTRG cell line which
is derived from the Jurkat cell line and has been stably
transfected with an HIV LTR-GFP construct. The JLTRG
cells were transfected with a Tat expression plasmid
along with HIV-LTR-DsRed, TASK or Vpu expression
vectors or empty vector control. In the absence of HIV-
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Figure 4 Vpu suppresses HIV-1 transcription. A. 293T cells were transfected with pNL4-3 and increasing amounts of Vpu expression plasmid.
After 48 hours a luciferase assay was performed to determine the effect of Vpu of HIV-1 transcription. Data are normalized to empty vector
control (EV). B. Transfected 293T cells were harvested, lysed and equal amounts of cell lysate protein were subjected to 4-12% SDS-PAGE. After
transfer to nitrocellulose membranes, VPU and β-tubulin proteins were revealed by immunoblotting with polyclonal antibodies followed by
chemilumenescence detection. C. 293T cells were transfected with an HIV-1 LTR-GFP construct that does not encode Tat along with TASK-3, Vpu
or empty vector. After 48 hours, the cells were harvested and subjected to flow cytometry analysis for GFP expression. Data shown are mean
fluorescence intensity of transfected cells. Non-transfected cells were used to set the negative gate. (* P < .001; Student T test was used to
determine statistical significance).
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used flow cytometry to assesses the expression of GFP and
DsRed as a measure of LTR activity and plotted the re-
spective MFI. As previously observed, both TASK and Vpu
proteins significantly suppressed transcription of the un-
integrated HIV-LTR-DsRed (Figure 5b). Interestingly, both
TASK and Vpu had only limited affect on transcription
from the integrated HIV LTR-GFP construct (Figure 5a).
Taken together these results indicate that TASK proteins
and Vpu preferentially suppress transcription of uDNA in
cells containing both integrated and uDNA.
TASK-1 and Vpu suppress HIV transcription in cells
infected with Integrase defective virus
Unintegrated copies of HIV-1 DNA are enriched in cells
infected with integrase-defective viruses. We took ad-
vantage of this phenomenon to confirm that Vpu and
TASK-1 proteins suppress transcription of uDNA. We
transfected Jurkat cells with either TASK-1 or Vpu and
then infected the cells with wildtype NL4-3-CFP or
integrase-defective NL4-3-D116N-YFP HIV-1. Thirty
hours after infection, RNA was isolated and used as tem-
plate for real-time PCR analysis of nef mRNA. As seenin Figure 6b, TASK and Vpu proteins significantly sup-
pressed nef transcription in cells infected with integrase
defective HIV-1 and minimally suppressed transcription
in cells infected with wildtype HIV-1 (Figure 6a). These
data confirmed our earlier results and strongly indicated
that TASK and Vpu preferentially suppress transcription
of uDNA.
Vpu and TASK-1 suppress unintegrated HIV-1 DNA in an
NFκβ-dependent manner
In a previous study, Bour et al. demonstrated that Vpu
interferes with NF-κβ activation by preventing degrad-
ation of Iκβ [32]. We explored this phenomenon as a
possible mechanism by which Vpu and TASK suppress
HIV-1 transcription. We transfected Jurkat cells with
empty vector, vectors expressing TASK-1, Vpu, or phos-
phorylation defective Vpu2/6 along with empty vector or
RelA(NF-κβ) in trans. Vpu2/6 does not cause degrad-
ation of Iκβ and subsequent NF-κβ activation. The cells
were then infected with either wildtype or integrase de-
fective HIV-1. Thirty hours after infection we isolated
RNA for real-time PCR analysis of nef mRNA. Vpu and
TASK minimally suppressed transcription of wild type
Tat - + + +
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Figure 5 TASK and Vpu proteins preferentially suppress unintegrated HIV-1 DNA. JLTRG cells, stable transfectants expressing HIV LTR-GFP
construct, were co-transfected with tat, HIV-LTR-DsRed and EV, Vpu or TASK-3GFP. Twenty four hours after transfection the cells were fixed,
permeabilized and subjected flow cytometry analysis. The mean fluorescence intensities of the double positive DsRed and GFP populations are
indicated in the graphs. (*P < .0005; Student T test was used to determine statistical significance).
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both proteins suppressed transcription of integrase de-
fective HIV-1 (Figure 7b). Interestingly, overexpression
of RelA reversed the suppression of transcription by
both Vpu and TASK proteins in cells infected with
integrase-defective HIV-1 (Figure 7a, 7b, 7c). These
results show that both Vpu and TASK suppress HIV-1
transcription through an NFκβ-dependent mechanism.
Our findings are consistent with the findings of Bour
et. al. that Vpu inhibits βTrCP-dependent degradation
of Iκβ since phosphorylation defective Vpu2/6, which
does not interfere with Iκβ degradation and subse-
quent NF-κβ activation, did not suppress HIV-1 tran-
scription. Furthermore overexpression of RelA in the































Figure 6 TASK-1 and Vpu preferentially suppress transcription of cell
transfected with empty vector (EV), TASK-1 or Vpu expression plasmids and
Twenty four hours after infection the cells were lysed and total RNA was is
Data shown are normalized to EV control. (* P = .0002; **P < .0001; Studenobserved for overexpression of RelA in wildtype Vpu
samples.
Discussion
Hsu et al. showed that a cellular K+ channel TASK-1 is
homologous to HIV-1 Vpu and that the first transmem-
brane domain of TASK-1 was functionally interchange-
able with Vpu [34]. They also observed that TASK-1 was
able to inhibit HIV-1 release and appeared to function
as an HIV-1 restriction factor. We wanted to follow up
on this observation and examine potential mechanisms
by which TASK proteins block HIV-1 replication. Using
a combination of transfection experiments and infec-
tions by wildtype and integrase-defective virus, we
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Figure 7 Suppression of HIV-1 transcription by Vpu and TASK-1 is abrogated by overexpression of RelA. Jurkat cells were transfected
with EV, TASK-1 or Vpu or EV + RelA, TASK-1 + RelA or Vpu + RelA and then infected with wildtype NL4-3CFP (A) or NL4-3-D116N-YFP (B).
Twenty four hours after infection the cells were lysed and total RNA was isolated and used as template for real-time PCR to measure nef mRNA.
Data shown are normalized to empty vector control (C). Transfected Jurkat cells were harvested, lysed and equal amounts of lysate protein were
subjected to 4-12% SDS-PAGE. After transfer to nitrocellulose membranes, Vpu, RelA and β-tubulin proteins were revealed by immunoblotting
with polyclonal antibodies and visualized by chemilumenescence detection. (* P < .0001; Student T test was used to determine statistical
significance).
Emeagwali and Hildreth Virology Journal 2012, 9:277 Page 8 of 12
http://www.virologyj.com/content/9/1/277suppress transcription of HIV-1 genes. This effect was
preferentially exerted on uDNA. The mechanism by
which TASK and Vpu differentially suppress transcrip-
tion from uDNA is not clear. We showed that the mech-
anism likely involves NF-κβ and it is not clear why this
factor would have a differential effect on integrated ver-
sus uDNA. It is possible that other critical proteins
required for transcription from uDNA but not integrated
genomes are either sequestered or degraded in the pres-
ence of Vpu or TASK. Integrated HIV DNA as part of
the cellular chromatin structure may require a different
set of cellular factors for transcription compared to
uDNA.
HIV-1 Vpu is a late gene product expressed after HIV-1
integration when sufficient levels of Rev is present for the
production of unspliced and singly spliced genes [41]. In
addition to antagonizing the host protein tetherin, degrad-
ing CD4 and enhancing virus release, Vpu decreases both
TNF-α and HIV-1-mediated activation of NF-κβ by inhibit-
ing βTrCP-dependent degradation of Iκβ [32]. Other viral
proteins such as Vpr, Tat, and gp120 have also been shown
to directly or indirectly affect NF-κβ regulation [42-46].
Prior to HIV-1 integration, uDNA produce early gene pro-
ducts: nef, rev and tat. After integration of HIV-1 proviral
DNA, when sufficient Rev levels are present, Vpu mRNA is
translated and the protein accumulates in infected cells.HIV-1 infection causes constitutive activation of NF-κβ
[47-49], a host transcription activator that resides in the
cytoplasm complexed to Iκβ. βTrCP-mediated degradation
of Iκβ frees NFκβ to migrate into the nucleus where it can
bind a variety of promoters including the HIV-1 LTR. Using
immunoprecipitation studies, Hsu et. al demonstrated an
association between Vpu, TASK-1 and βTrCP. They also
showed that TASK-1 protein is degraded after infection in
primary CD4+ T lymphocytes [34]. These findings the led
authors to speculate that Vpu may mediate the degradation
of TASK-1 through the βTrCP ubiquitin ligase pathway
similar to Vpu-mediated degradation of CD4 and Iκβ
[32,34]. Our findings with both functional and nonfunc-
tional TASK proteins along with the previously described
interaction between TASK-1 and βTrCP indicate that
TASK-1 and Vpu may share a common mechanism of sup-
pressing HIV-1 transcription: decreased NF-κβ activation
by inhibiting βTrCP-dependent Iκβ degradation.
Bour et al. showed that overexpression of sub-genomic
constructs expressing all HIV-1 proteins except Gag and
Pol led to a moderate 3-fold activation of NF-κβ in the
presence of Vpu and a 14-fold enhancement in the absence
of Vpu [32]. Similar results were obtained when full-length
HIV-1 constructs were used. Thus Vpu negatively modu-
lates of NF-κβ activation and this would lead to lower levels
of HIV-1 transcription in some cell types. This data is
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strate that suppression of HIV-1 transcription by Vpu and
TASK proteins can be abrogated by overexpression of RelA.
Interestingly, our results show that Vpu and TASK proteins
exert their negative effect on HIV-1 transcription preferen-
tially on uDNA. Our findings are not in conflict with those
of Bour et al. since they used largely transfection-based
studies to examine the effect of Vpu on NF-κβ activation.
In such studies, proviral genomes remain unintegrated.
We also demonstrated that homologous TASK proteins
profoundly suppressed HIV-1 transcription. TASK-1 and
TASK-3 proteins are constitutively expressed in primary
CD4+ T cells and contribute 40% of the K+ efflux needed to
mediate Ca2+-dependent T cell effector function, namely T
cell proliferation and the production of IFNγ and IL-2 [50].
IFNγ induces TNFα production leading to NF-κβ activation
and subsequently HIV-1 LTR mediated transcription. T cell
effector function is a Ca2+ dependent immune response
that also leads to the destruction of virally infected cells
and the priming of neighboring T cells [50]. TASK-
mediated enhancement of Ca2+-dependent transcription of
cytokines after HIV-1 infection may be a component of the
host cell response to restrict HIV-1 replication. Since TASK
proteins can suppress HIV-1 transcription and they play a
role in generating critical cytokines needed to combat the
virus, TASK proteins can be viewed as HIV-1 host restric-
tion factors. This is consistent with the observation that
after HIV-1 infection, Vpu leads to the degradation of
TASK proteins [34]. However, modulation of transcription
from uDNA may be essential to efficient replication as this
function is present in Vpu and therefore maintained by the
virus.
Our data and model are not in conflict with the earlier
studies of Wu and others showing efficient expression of
early genes from episomal HIV DNA [20,24,30,41,51-
54]. In our model, TASK, as a constitutively expressed
cellular protein, would suppress expression of early
genes from episomal DNA as part of the cellular re-
sponse to the virus. TASK may represent the natural si-
lencing mechanism and Vpu, which is able to cause
degradation of TASK, may represent the virus’ mechan-
ism for suppressing the cellular response. It is extremely
intriguing, that the virus protein that is able to destroy
the restricting protein (TASK) has the same activity it-
self. Thus, initially Vpu’s role may be to suppress TASK
and then later it suppresses transcription from uDNA
after sufficient early gene products have formed to drive
expression from integrated DNA.
Conclusion
Our findings have important implications given the
increased use of integrase inhibitors in antiretroviral
therapy. In the presence of integrase inhibitors uDNA
accumulates because more substrates are available forthe non-homologous end joining pathways when inte-
gration is blocked [55,56]. Although uDNA templates
are transcriptionally active and can be suppressed by
TASK protein, the presence of uDNA prior to integra-
tion has been associated with activation and productive
infection in resting T-cells via expression of Tat and Nef
from uDNA. When HIV-1 integration is blocked CD4,
CCR5 and CXCR4 are down regulated by Nef, leading to
a restriction of superinfection events [57-60]. In
addition, HLA molecules recognized by helper [61] and
cytotoxic T-cells are down regulated by Nef while HLA
molecules that are recognized by natural killer cells are
not affected by Nef [62-65]. Therefore early production
of Nef from uDNA may be important for immune eva-
sion by HIV-1 [61]. In non-dividing cells with slower
viral replication kinetics, such as macrophages, uDNA is
biologically active and very stable. In these cells there is
persistent transcription, primarily of early genes, of the
uDNA. In infections with integrase defective lentiviral
vectors in animal models, reservoirs of uDNA are rela-
tively long lived [66,67].
The regulation of uDNA is important since replication
of integrase-defective viruses can be rescued by super-
infection with wild type virus [26,68]. Vpr promotes
transcription from the uDNA, and after integration
when Rev protein is present, transcripts from uDNA can
be exported from the nucleus and translated. Therefore
proteins encoded by uDNA can participate in virion as-
sembly. Both RNA and protein products from uDNA
can be packaged into virions, providing an opportunity
for recombination and second round infections [68].
This phenomenon could contribute meaningfully to the
genetic diversity of HIV-1.
Materials and methods
Reagents, plasmids, and antibodies
TY191F [69], rodent TASK-1, rodent TASK-3 and IRK-1
expression plasmids were kind gifts from Dr. Douglas
Bayliss (University of Virginia Charlottesville, VA). Human
TASK-1, human TASK-3 and RelA-myc expression vec-
tors were obtained from Origene (Rockville, MD). The
Vpu-eGFP expression vector was a kind gift from Dr.
Vasundhara Varthakavi (National Institutes of Health
Bethesda, MD). Expression plasmids for codon-optimized
Vpu (pcDNA-Vphu), phosphorylation defective mutant
pcDNA-Vphu2/6 and a polyclonal antibody to Vpu were
generous gifts from Klaus Strebel (National Institutes of
Health, Bethesda, MD) and have been described elsewhere
[32]. A monoclonal antibody against HIV-1 Gag (GagM1)
was generated in our laboratory. Commercially available
antibodies against HIV-1 Gag KC57-RD1 (Beckman
Coulter), TASK-1 (Chemicon) and β-tubulin (Santa
Cruz Biotechnology) were used for immunoblotting
experiments. Secondary antibodies (horseradish peroxidase-
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H+L (GAMH+L) and Fcγ specific (GAMFc) were obtained
from Jackson ImmunoResearch Laboratories. Cell viability
was measured using the Invitrogen fluorescence based
LIVE/DEAD cell assay kit.
Viruses
HIV-1 was prepared in 293T cells by transfection of
plasmid DNA (pNL4-3-CFP and pNL4-3 D116N-YFP
(kind gifts from Dr. David Levi) [26], and pNL4-3,
pNL4-3-Udel (kind gift from Dr. Klaus Strebel)) using
Lipofectamine (Invitrogen) per the manufacturer's instruc-
tions. The supernatants containing virus particles were
harvested after 48hr of culture, filtered through a 0.2 mi-
cron filter and pelleted through a 20% sucrose cushion
(100,000×g, 1hr). All virus preparations were treated with
DNase I to remove plasmid DNA.
Cells
The Jurkat T cell line was obtained from the American
Type Culture Collection (ATCC) and cultured in
complete RPMI (cRPMI) (RPMI, 10 mM HEPES, 2 mM
L-glutamine, 10% fetal bovine serum (FBS). The JLTRG
cell line was obtained from Dr. Olaf Kutsch through the
AIDS Research and Reference Reagent Program, Div-
ision of AIDS, NIAID, NIH: JLTRG (Cat #11587). HEK
293T cell line was obtained from the ATCC and cultured
in complete Dulbecco modified Eagle medium (cDMEM)
DMEM, 10 mM HEPES, 2 mM L-glutamine, 10% fetal bo-
vine serum (FBS). Cell viability was assessed by trypan
blue exclusion.
Infections and transfections
HEK 293T cells were plated in 60-cm dishes (5 × 105
cells/2ml) and co-transfected with pNL4-3-Luc and
TASK or Vpu cDNA. After washing and 48 hours of cul-
ture as above, the cells were lysed and lysates were ana-
lyzed for luciferase activity with the Promega luciferase
assay kit as per manufacturer’s instructions. Jurkat cells
were transfected with Vpu-eGFP or TASK-GFP DNA
using the human T cell Nucleofector system (Amaxa,
Gaithersburg, MD) per the manufacturer's instructions.
After 6 hours cells were infected by spinoculation with
50ng of either wildtype NL4-3-CFP or integrase defect-
ive NL4-3D116N-YFP virus. Infection and transfection
efficiencies were determined by either western blot ana-
lysis or flow cytometry. Briefly, for flow cytometry, cells
were fixed with 2% paraformaldehyde, permeabilized
using 0.1% saponin, and then stained with the mouse
KC57-RD1 (anti-Gag) or an isotype-matched control
antibody. Stained cells were analyzed on a Beckman
FACS Calibur flow cytometer equipped with Cell Quest
software. Viral infection and transfection rates were
expressed as percentages of cells staining positively withthe anti-p24 antibody or expressing CFP, YFP or GFP as
appropriate.Virus titer determinations
Two days after transfection with virus DNA constructs,
HIV-1 Gag was measured in the cell culture superna-
tants and cell lysates using a capture ELISA.Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and immunoblotting
Cell lysates were prepared by adding RIPA lysis buffer
containing protease inhibitor cocktail (Roche) to cell pel-
lets followed by incubation for 30 min on ice. Protein
concentrations of cell lysates were determined using a
bicinchoninic acid protein assay kit (Pierce-Rockford, IL).
Equal amounts of protein were taken up in gel loading
buffer and the samples were heated at 70°C for 10 min be-
fore loading onto a 4 - 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis gradient gels (NuPAGE
Novex Bis-Tris gels; Invitrogen). Proteins were transferred
onto a Hybond-P polyvinylidene difluoride membrane
(Amersham Biosciences, NJ) following manufacturers
protocol. The membranes were blocked in 5% powdered
milk in PBS, 0.1% Tween 20 and then probed with TASK-
1 (1:1000), Vpu (1:000) or NF-κβ (1:500 dilution) for 60
min at 25°C . The membranes were then incubated for 60
min with horseradish peroxidase-conjugated, anti-mouse
(1:10,000) or anti-rabbit (1:10,000) immunoglobulin G
secondary antibodies (Promega, San Luis Obispo, CA)
and developed using Super Signal chemiluminescence
(Pierce). Bands were visualized on Denville Scientific film.Real-time PCR
Total RNA was isolated using a Qiagen total RNA puri-
fication kit as per manufacturer’s instructions. RNA was
treated with Qiagen’s DNase I and reverse-transcribed
using the Invitrogen Superscript cDNA synthesis kit. The
cDNA was treated with RNase H and then subjected to
real time PCR with HIV-1 gene-specific primers. Real-
time PCR conditions and primers to detect HIV-1 Nef-2
mRNA are described in detail elsewhere [70].Statistical analysis
All experiments were performed three to six times, and
representative experiments are shown. The Student t test
was used to determine the statistical significance of the
results.
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